The Latest Cardiac and Vascular News
Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation MARLBOROUGH, Mass. and CHICAGO, Nov. 16, 2024 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced…
MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device. Designed to further advance the procedural performance and safety […]
Minimally invasive procedure dramatically reduces stroke risk for certain atrial fibrillation patients HOPEWELL, N.J., April 21, 2023 /PRNewswire/ — Physicians and staff from Capital Health’s Heart and Vascular Institute recently performed their first Watchman implant procedure at Capital Health Regional Medical Center […]
Innovative Transseptal Access System Is First and Only to Feature Integrated Dilator and Needle to Reduce Exchanges CARLSBAD, Calif., June 27, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way […]
The permanent heart implant is the only FDA-approved device for the reduction of stroke risk in patients with non-valvular atrial fibrillation LAGUNA HILLS, CA – Oct. 28, 2021 — The MemorialCare Heart & Vascular Institute at Saddleback Medical Center recently […]
– New data presented at ESC Congress 2021 and simultaneously published in Circulation show Amulet Occluder was superior in left atrial appendage (LAA) closure and noninferior on safety and effectiveness endpoints compared to Watchman device – Amulet device is the […]
EchoPixel’s pre-planning and intra-operative technologies reduced complex heart procedure time while improving quality of outcomes ST. CLOUD, Minn., June 23, 2021 (GLOBE NEWSWIRE) — CentraCare, one of the largest health systems in Minnesota, has successfully completed the first structural heart procedure […]
LAGUNA HILLS, Calif., June 24, 2019 /PRNewswire/ — MemorialCare Saddleback Medical Center cardiologists are among a select group of specialists to successfully implant a device in patients to help keep harmful blood clots from entering the blood stream and potentially causing a stroke. Cardiologists […]
MARLBOROUGH, Mass., March 12, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced key data presentations that will be featured at the annual congress of the European Heart Rhythm Association (EHRA) in Barcelona, Spain, on March 18-20. Notably, there will be three late-breaking clinical trials […]
DENVER and MARLBOROUGH, Mass., Nov. 2, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) announced final five-year outcomes data from the PREVAIL study of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device today during a late-breaking clinical trial session at the 29th Transcatheter Cardiovascular Therapeutics (TCT), the […]
